News Cost the barrier, but Novo not giving up on insulin pill, sa... Cost of pill will be too much for payers to stomach, says Novo.
Views & Analysis The 'game changers' in diabetes: Novo and Lilly battle it ou... Two diabetes drugs, Lilly and Boehringer Ingelheim’s (BI) Jardiance and Novo Nordisk’s Victoza, have shown they can go beyond lowering blood sugar, and actually save lives and cut heart attacks
News Novo's next-gen diabetes drug could be best at cutting heart... Novo boosted by results from next-gen GLP-1.
News Novo posts strong performance, but US pricing pressure grows Pharmacy benefit managers and arrival of biosimilars making life difficult for diabetes companies
News Third Rock in $2bn drug-hunting pact with China's Funnel New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
